Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Profit After Tax (2021 - 2025)

Historic Profit After Tax for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to -$12.9 million.

  • ProQR Therapeutics' Profit After Tax fell 4449.79% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.2 million, marking a year-over-year decrease of 8137.66%. This contributed to the annual value of -$30.0 million for FY2024, which is 15.84% down from last year.
  • Latest data reveals that ProQR Therapeutics reported Profit After Tax of -$12.9 million as of Q3 2025, which was down 4449.79% from -$13.8 million recorded in Q2 2025.
  • Over the past 5 years, ProQR Therapeutics' Profit After Tax peaked at $20.9 million during Q4 2021, and registered a low of -$23.5 million during Q3 2022.
  • Moreover, its 5-year median value for Profit After Tax was -$9.5 million (2023), whereas its average is -$6.8 million.
  • Per our database at Business Quant, ProQR Therapeutics' Profit After Tax skyrocketed by 7488.95% in 2023 and then crashed by 37555.1% in 2025.
  • Quarter analysis of 5 years shows ProQR Therapeutics' Profit After Tax stood at $20.9 million in 2021, then crashed by 165.03% to -$13.6 million in 2022, then soared by 56.52% to -$5.9 million in 2023, then crashed by 68.55% to -$9.9 million in 2024, then fell by 29.4% to -$12.9 million in 2025.
  • Its Profit After Tax was -$12.9 million in Q3 2025, compared to -$13.8 million in Q2 2025 and -$10.6 million in Q1 2025.